Negotiating Ambiguities in Life and Death

May 30, 2016

By Margaret Hayden

18th Annual Henry K. Beecher Prize in Medical Ethics. 

By Maya Sabatello and Paul S. Appelbaum

HealthDay News

Wednesday, July 13, 2016

By Karen Pallarito

Our speakers reviewed and discussed the history of a technique called Facilitated Communication, purportedly used to communicate with individuals with severe autism,  developmental delay, or brain injuries. The technique has since been comprehensively debunked--watch and learn how providers can go wrong by failing to adhere to standards of evidence.

The Wall Street Journal
June 26, 2016
By Amy Dockser Marcus, HMS MBE '17

The Osterrieder family became involved in a transplant case that raised a difficult issue with which the organ-donation community is still wrestling.

The Wall Street Journal
June 24, 2016
By Amy Dockser Marcus

David Adox had ALS and wanted to be an organ donor. But it wasn’t easy to make it happen.

If a neurosurgeon develops a new technique, when can it be considered innovation, and when should it be considered investigation? 

The Boston Globe
By Robert Weisman

Committee member Aaron S. Kesselheim, associate professor at Harvard Medical School, said “the studies provided by [Sarepta] were not adequate and well controlled.” But he acknowledged that it remains an “open question” whether Eteplirsen produces a clinical benefit to patients who take it.

Explore the pros and cons of managing genetic information via public and proprietary companies. 

Even in the US, some controversy persists over the conceptual defensibility of brain death. Around the world, the philosophical defensibility of brain death is even more debatable.